SEC Form 4 · accession 0001591467-26-000004
Akebia Therapeutics, Inc. · AKBA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P. Butler
Officer — CEO and President · Director
Period of report
Aug 6, 2026
Accepted (ET)
Aug 10, 2026 · 4:08 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001517022
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 6, 2026 | M | 350,000 | $0.63 | A | 3,718,564 | D | |
| Common Stock | holding | — | — | — | 159,928 | I | Held by Dorothy Butler Revocable Trust November 20, 2007 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F2 | $0.63 | Aug 6, 2026 | M | 350,000 | D | — | Jan 31, 2033 | Common Stock | 350,000 | 525,000 | D |
Explanation of responses
- F1Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2026 under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan.
- F2The options were granted by the Issuer on January 31, 2023 and vest over four years: 25% of the options vested on January 31, 2024 with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.